PuSH - Publikationsserver des Helmholtz Zentrums München

Fukumura, K.* ; Sperotto, L. ; Seuss, S. ; Kang, H.-S. ; Yoshimoto, R.* ; Sattler, M. ; Mayeda, A.*

SAP30BP interacts with RBM17/SPF45 to promote splicing in a subset of human short introns.

Cell Rep., DOI: 10.1016/j.celrep.2023.113534:113534 (2023)
Verlagsversion DOI PMC
Creative Commons Lizenzvertrag
Human pre-mRNA splicing requires the removal of introns with highly variable lengths, from tens to over a million nucleotides. Therefore, mechanisms of intron recognition and splicing are likely not universal. Recently, we reported that splicing in a subset of human short introns with truncated polypyrimidine tracts depends on RBM17 (SPF45), instead of the canonical splicing factor U2 auxiliary factor (U2AF) heterodimer. Here, we demonstrate that SAP30BP, a factor previously implicated in transcriptional control, is an essential splicing cofactor for RBM17. In vitro binding and nuclear magnetic resonance analyses demonstrate that a U2AF-homology motif (UHM) in RBM17 binds directly to a newly identified UHM-ligand motif in SAP30BP. We show that this RBM17-SAP30BP interaction is required to specifically recruit RBM17 to phosphorylated SF3B1 (SF3b155), a U2 small nuclear ribonucleoprotein (U2 snRNP) component in active spliceosomes. We propose a mechanism for splicing in a subset of short introns, in which SAP30BP guides RBM17 in the assembly of active spliceosomes.
Impact Factor
Scopus SNIP
Altmetric
8.800
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cp: Molecular Biology ; Rbm17 ; Sab30bp ; Sf3b1 ; Sf3b155 ; Spf45 ; U2 Snrnp ; U2af Heterodimer ; U2af-homology Motif ; Uhm ; Uhm-ligand Motif ; Ulm ; Polypyrimidine Tract ; Pre-mrna Splicing ; Short Intron
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 2211-1247
e-ISSN 2211-1247
Zeitschrift Cell Reports
Quellenangaben Band: , Heft: , Seiten: , Artikelnummer: 113534 Supplement: ,
Verlag Cell Press
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
PubMed ID 38065098
Erfassungsdatum 2023-12-19